Citation: Je. Gallant et al., THE EFFECT OF ADJUNCTIVE CORTICOSTEROIDS FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA ON MORTALITY AND SUBSEQUENT COMPLICATIONS, Chest, 114(5), 1998, pp. 1258-1263
Authors:
PONS V
GREENSPAN D
LOZADANUR F
MCPHAIL L
GALLANT JE
TUNKEL A
JOHNSON CC
MCCARTY J
PANZER H
LEVENSTEIN M
BARRANCO A
GREEN S
Citation: V. Pons et al., OROPHARYNGEAL CANDIDIASIS IN PATIENTS WITH AIDS - RANDOMIZED COMPARISON OF FLUCONAZOLE VERSUS NYSTATIN ORAL SUSPENSIONS, Clinical infectious diseases, 24(6), 1997, pp. 1204-1207
Authors:
MAENZA JR
MERZ WG
ROMAGNOLI MJ
KERULY JC
MOORE RD
GALLANT JE
Citation: Jr. Maenza et al., INFECTION DUE TO FLUCONAZOLE-RESISTANT CANDIDA IN PATIENTS WITH AIDS - PREVALENCE AND MICROBIOLOGY, Clinical infectious diseases, 24(1), 1997, pp. 28-34
Authors:
CHAISSON RE
KERULY JC
MCAVINUE S
GALLANT JE
MOORE RD
Citation: Re. Chaisson et al., EFFECTS OF AN INCENTIVE AND EDUCATION-PROGRAM ON RETURN RATES FOR PPDTEST READING IN PATIENTS WITH HIV-INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 11(5), 1996, pp. 455-459
Citation: Je. Gallant et Ah. Ko, CAVITARY PULMONARY-LESIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 22(4), 1996, pp. 671-682
Authors:
GALLANT JE
ABRAMS JE
MCAVINUE SM
QUINN TC
CHAISSON RE
Citation: Je. Gallant et al., PREVIOUSLY UNRECOGNIZED HIV-INFECTION AMONG HOSPITALIZED-PATIENTS, Infectious diseases in clinical practice, 5(6), 1996, pp. 380-386
Citation: Lw. Cheever et al., PROPHYLAXIS AGAINST OPPORTUNISTIC INFECTIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Western journal of medicine, 165(1-2), 1996, pp. 67-73
Citation: Je. Gallant et al., ACYCLOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS PATIENTS - REPLY, The Journal of infectious diseases, 173(2), 1996, pp. 505-507
Authors:
MAENZA JR
KERULY JC
MOORE RD
CHAISSON RE
MERZ WG
GALLANT JE
Citation: Jr. Maenza et al., RISK-FACTORS FOR FLUCONAZOLE-RESISTANT CANDIDIASIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, The Journal of infectious diseases, 173(1), 1996, pp. 219-225
Citation: Je. Gallant et al., THE EFFECT OF PROPHYLAXIS ON THE OUTCOME OF HIV-ASSOCIATED PNEUMOCYSTIS-CARINII PNEUMONIA, Chest, 109(2), 1996, pp. 587-587
Citation: Ah. Ko et al., NON-HODGKINS-LYMPHOMA AND KAPOSIS-SARCOMA CAUSING CAVITARY LUNG LESIONS IN A PATIENT WITH AIDS - AN HIV-ASSOCIATED COLLISION TUMOR, AIDS, 9(10), 1995, pp. 1195-1197
Authors:
GALLANT JE
MOORE RD
KERULY J
RICHMAN DD
CHAISSON RE
BARTLETT J
MCAVINUE S
BRYSON Y
COHEN H
FISCHL M
BOLIN T
KESSLER H
BURROUGH Y
MILDVAN D
FOX A
RICHMAN D
FREEMAN B
SIMON G
GRABOWY KW
CHERNOFF D
DUFF P
THOMPSON S
BARRETT K
AWE R
CHAPMAN R
LEONARD S
TURNER P
HAWKINS M
MURRAY H
BOWERS J
LANE C
TILSON H
ANDREWS E
SMILEY L
Citation: Je. Gallant et al., LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, The Journal of infectious diseases, 172(2), 1995, pp. 346-352
Authors:
GALLANT JE
MCAVINUE SM
MOORE RD
BARTLETT JG
STANTON DL
CHAISSON RE
Citation: Je. Gallant et al., THE IMPACT OF PROPHYLAXIS ON OUTCOME AND RESOURCE UTILIZATION IN PNEUMOCYSTIS-CARINII PNEUMONIA, Chest, 107(4), 1995, pp. 1018-1023
Citation: Je. Gallant et al., OSTEOMYELITIS DUE TO MYCOBACTERIUM-KANSASII AND MYCOBACTERIUM-AVIUM COMPLEX IN AN HIV-INFECTED PATIENT, Infectious diseases in clinical practice, 3(4), 1994, pp. 297-299
Authors:
GALLANT JE
MOORE RD
RICHMAN DD
KERULY J
CHAISSON RE
BARTLETT J
MCAVINUE S
BRYSON Y
COHEN H
FISCHL M
BOLIN T
BURROUGH Y
MILDVAN D
FOX A
RICHMAN D
FREEMAN B
SIMON G
GRABOWY KW
CHERNOFF D
DUFF P
THOMPSON S
BARRETT K
AWE R
LEONARD S
TURNER P
HAWKINS M
MURRAY H
BOWERS J
TILSON H
SMILEY L
Citation: Je. Gallant et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, Archives of internal medicine, 154(5), 1994, pp. 566-572
Citation: Je. Gallant et al., PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION, Annals of internal medicine, 120(11), 1994, pp. 932-944
Authors:
CHAISSON RE
STANTON DL
GALLANT JE
RUCKER S
BARTLETT JG
MOORE RD
Citation: Re. Chaisson et al., IMPACT OF THE 1993 REVISION OF THE AIDS CASE-DEFINITION ON THE PREVALENCE OF AIDS IN A CLINICAL SETTING, AIDS, 7(6), 1993, pp. 857-862
Authors:
GALLANT JE
ELDRED LJ
LESLIE JM
CHAISSON RE
QUINN TC
Citation: Je. Gallant et al., IMPACT OF THE 1993 REVISION OF THE CDC CASE-DEFINITION ON THE PERFORMANCE OF THE WHO AND PAHO CLINICAL CASE DEFINITIONS FOR AIDS, AIDS, 7(10), 1993, pp. 1396-1397
Citation: Je. Gallant et al., FACTORS ASSOCIATED WITH INCREASED RISK OF ACQUIRING CYTOMEGALOVIRUS DISEASE IN AIDS PATIENTS - REPLY, The Journal of infectious diseases, 168(4), 1993, pp. 1072-1072